- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
Patent holdings for IPC class A61K 31/7048
Total number of patents in this class: 4629
10-year publication summary
|
336
|
324
|
333
|
354
|
399
|
459
|
428
|
376
|
341
|
241
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 9322 |
65 |
| Boehringer Ingelheim International GmbH | 4646 |
63 |
| The Board of Trustees of the University of Illinois | 2714 |
39 |
| Suntory Holdings Limited | 2039 |
32 |
| Boehringer Ingelheim Vetmedica GmbH | 1276 |
31 |
| Massachusetts Institute of Technology | 10110 |
27 |
| The Regents of the University of California | 20087 |
26 |
| AMOREPACIFIC Corporation | 2848 |
25 |
| Korea Research Institute of Bioscience and Biotechnology | 1061 |
23 |
| Insmed Incorporated | 235 |
22 |
| Phoenix Biotechnology, Inc. | 49 |
22 |
| Evonik Operations GmbH | 4166 |
22 |
| Amazentis SA | 164 |
21 |
| Zoetis Services LLC | 1536 |
21 |
| The Brigham and Women's Hospital, Inc. | 2214 |
20 |
| RedHill Biopharma Ltd. | 98 |
20 |
| Novartis AG | 10725 |
19 |
| Galderma Holding S.A. | 685 |
19 |
| Wisconsin Alumni Research Foundation | 3883 |
18 |
| Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | 26 |
18 |
| Other owners | 4076 |